Health Care·Health Care Services·$21.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.80 | N/A | +0.78% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.80 | N/A | +0.78% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, indicating a focus on operational efficiency. However, they did not provide specific revenue guidance.
We are pleased with our EPS performance this quarter.
While we did not provide specific revenue figures, we remain focused on our strategic initiatives.
LabCorp's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock reacted negatively, declining by 0.55%, possibly due to the lack of revenue figures and guidance. Investors may be cautious as they await more detailed financial insights in future reports.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CSX CORP
Jul 16, 2013